Ειδοποίηση Μελετητή:[ intitle:Bioprinting ]
Current Developments in Multifunctional Smart Materials for 3D/4D Bioprinting
NJ Castro, C Meinert, P Levett, DW Hutmacher - Current Opinion in Biomedical …, 2017
Abstract Tissue engineering and regenerative medicine (TE&RM) has made continuous
advancements by extending three-dimensional (3D) printing towards the development and
fabrication of biomimetic scaffolds composed of biomimetic natural and synthetic materials.
advancements by extending three-dimensional (3D) printing towards the development and
fabrication of biomimetic scaffolds composed of biomimetic natural and synthetic materials.
Towards biologically relevant synthetic designer matrices in 3D bioprinting for tissue engineering and regenerative medicine
RM Costa, S Rauf, CAE Hauser - Current Opinion in Biomedical Engineering, 2017
Abstract 3D bioprinting is one of the most promising technologies in tissue engineering and
regenerative medicine. As new printing techniques and bioinks are getting developed, new
cellular constructs with high resolution and functionality arise. Different to bioinks of animal,
regenerative medicine. As new printing techniques and bioinks are getting developed, new
cellular constructs with high resolution and functionality arise. Different to bioinks of animal,
3D bioprinting of soft materials-based regenerative vascular structures and tissues
Z Zhang, B Wang, D Hui, J Qiu, S Wang - Composites Part B: Engineering, 2017
Abstract Vascularization is a leading limitation for the clinical application of in vitro
engineered tissue constructs because of the insufficient blood supply in the initial phase
after implantation. In spite of decades of progress in the tissue engineering field,
engineered tissue constructs because of the insufficient blood supply in the initial phase
after implantation. In spite of decades of progress in the tissue engineering field,
3D Bioprinting for Drug Discovery and Development in Pharmaceutics
W Peng, P Datta, B Ayan, V Ozbolat, D Sosnoski… - Acta Biomaterialia, 2017
Abstract Successful launch of a commercial drug requires significant investment of time and
financial resources wherein late-stage failures become a reason for catastrophic failures in
drug discovery. This calls for infusing constant innovations in technologies, which can give
financial resources wherein late-stage failures become a reason for catastrophic failures in
drug discovery. This calls for infusing constant innovations in technologies, which can give
Large scale production and controlled deposition of single HUVEC spheroids for bioprinting applications.
L Gutzweiler, S Kartmann, K Troendle, L Benning… - Biofabrication, 2017
We present 1.) a fast and automated method for large scale production of HUVEC spheroids
based on the hanging drop method and 2.) a novel method for well-controlled lateral
deposition of single spheroids by drop-on-demand printing. Large scale spheroid production
based on the hanging drop method and 2.) a novel method for well-controlled lateral
deposition of single spheroids by drop-on-demand printing. Large scale spheroid production
[HTML] Perspective: Fabrication of integrated organ-on-a-chip via bioprinting
Q Yang, Q Lian, F Xu - Biomicrofluidics, 2017
Organ-on-a-chip has emerged as a powerful platform with widespread applications in
biomedical engineering, such as pathology studies and drug screening. However, the
fabrication of organ-on-a-chip is still a challenging task due to its complexity. For an
biomedical engineering, such as pathology studies and drug screening. However, the
fabrication of organ-on-a-chip is still a challenging task due to its complexity. For an
Αυτή η Ειδοποίηση του Μελετητή Google σας προσφέρεται από τη Google
Ακύρωση ειδοποίησης
Δημιουργία λίστας των ειδοποιήσεών μου
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου